| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.44 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.006 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |